LRRK2 and Parkinson disease: In conclusion, the absence of the LRRK2 G2019S mutation in Emirati and Saudi PD patients underscores significant genetic heterogeneity within the Arab world and supports the hypothesis of an Amazigh founder effect underlying its high prevalence in the Maghreb.